198 related articles for article (PubMed ID: 22467872)
21. Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.
Krueger E; Brown AC
Mol Oral Microbiol; 2020 Jun; 35(3):85-105. PubMed ID: 32061022
[TBL] [Abstract][Full Text] [Related]
22. Resolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse model.
Stenderup K; Rosada C; Dam TN; Salerno E; Belinka BA; Kachlany SC
J Invest Dermatol; 2011 Oct; 131(10):2033-9. PubMed ID: 21654835
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.
Brown AC; Koufos E; Balashova NV; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2016 Feb; 31(1):94-105. PubMed ID: 26352738
[TBL] [Abstract][Full Text] [Related]
24. Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response.
Johansson A
Toxins (Basel); 2011 Mar; 3(3):242-59. PubMed ID: 22069708
[TBL] [Abstract][Full Text] [Related]
25. Cranberry Proanthocyanidins Neutralize the Effects of
Ben Lagha A; Howell A; Grenier D
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483
[No Abstract] [Full Text] [Related]
26. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.
Chang EH; Giaquinto P; Huang J; Balashova NV; Brown AC
Mol Oral Microbiol; 2020 Jan; 35(1):29-39. PubMed ID: 31816197
[TBL] [Abstract][Full Text] [Related]
27. Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin.
Dileepan T; Kachlany SC; Balashova NV; Patel J; Maheswaran SK
Infect Immun; 2007 Oct; 75(10):4851-6. PubMed ID: 17635865
[TBL] [Abstract][Full Text] [Related]
28. Purification of secreted leukotoxin (LtxA) from Actinobacillus actinomycetemcomitans.
Kachlany SC; Fine DH; Figurski DH
Protein Expr Purif; 2002 Aug; 25(3):465-71. PubMed ID: 12182827
[TBL] [Abstract][Full Text] [Related]
29. Monodisperse and LPS-free Aggregatibacter actinomycetemcomitans leukotoxin: interactions with human β2 integrins and erythrocytes.
Reinholdt J; Poulsen K; Brinkmann CR; Hoffmann SV; Stapulionis R; Enghild JJ; Jensen UB; Boesen T; Vorup-Jensen T
Biochim Biophys Acta; 2013 Feb; 1834(2):546-58. PubMed ID: 23234758
[TBL] [Abstract][Full Text] [Related]
30. Solving the riddle: Unraveling the mechanisms of blocking the binding of leukotoxin by therapeutic antagonists in periodontal diseases.
Abdullahi M; Olotu FA; Soliman ME
J Cell Biochem; 2018 Nov; 119(11):9364-9379. PubMed ID: 30129224
[TBL] [Abstract][Full Text] [Related]
31. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin.
Kelk P; Johansson A; Claesson R; Hänström L; Kalfas S
Infect Immun; 2003 Aug; 71(8):4448-55. PubMed ID: 12874324
[TBL] [Abstract][Full Text] [Related]
32. Sialic acid residues are essential for cell lysis mediated by leukotoxin from Aggregatibacter actinomycetemcomitans.
Munksgaard PS; Skals M; Reinholdt J; Poulsen K; Jensen MR; Yang C; Leipziger J; Vorup-Jensen T; Praetorius HA
Infect Immun; 2014 Jun; 82(6):2219-28. PubMed ID: 24643533
[TBL] [Abstract][Full Text] [Related]
33.
Looh SC; Soo ZMP; Wong JJ; Yam HC; Chow SK; Hwang JS
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051027
[TBL] [Abstract][Full Text] [Related]
34. Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes.
Munksgaard PS; Vorup-Jensen T; Reinholdt J; Söderström CM; Poulsen K; Leipziger J; Praetorius HA; Skals M
Cell Microbiol; 2012 Dec; 14(12):1904-20. PubMed ID: 22906303
[TBL] [Abstract][Full Text] [Related]
35.
Kelk P; Moghbel NS; Hirschfeld J; Johansson A
Pathogens; 2022 Jan; 11(2):. PubMed ID: 35215102
[TBL] [Abstract][Full Text] [Related]
36. Aggregatibacter actinomycetemcomitans induces detachment and death of human gingival epithelial cells and fibroblasts via elastase release following leukotoxin-dependent neutrophil lysis.
Hiyoshi T; Domon H; Maekawa T; Nagai K; Tamura H; Takahashi N; Yonezawa D; Miyoshi T; Yoshida A; Tabeta K; Terao Y
Microbiol Immunol; 2019 Mar; 63(3-4):100-110. PubMed ID: 30817027
[TBL] [Abstract][Full Text] [Related]
37. Leukotoxin kills rodent WBC by targeting leukocyte function associated antigen 1.
DiFranco KM; Kaswala RH; Patel C; Kasinathan C; Kachlany SC
Comp Med; 2013 Aug; 63(4):331-7. PubMed ID: 24209968
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Bacterial Toxin Activity by the Nuclear Stain, DRAQ5™.
Webb JN; Koufos E; Brown AC
J Membr Biol; 2016 Aug; 249(4):503-11. PubMed ID: 27039399
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.
Fagerberg SK; Jakobsen MR; Skals M; Praetorius HA
Infect Immun; 2016 Nov; 84(11):3114-3130. PubMed ID: 27528275
[TBL] [Abstract][Full Text] [Related]
40. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans.
Johansson A; Claesson R; Hänström L; Sandström G; Kalfas S
J Periodontal Res; 2000 Apr; 35(2):85-92. PubMed ID: 10863962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
